Rx Rundown: BridgeBio Pharma, Vertex Pharmaceuticals, Allakos and more
Check out this week’s medical marketing news, people on the move and industry chatter.
Stay updated with breaking news from Andrei Floroiu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Check out this week’s medical marketing news, people on the move and industry chatter.
Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.
By Colin Kellaher Vaxart's top executive, Andrei Floroiu, has resigned as president, chief executive and a director of the clinical-stage biotechnology...
Chief Executive Officer Andrei Floroiu Resigns Chair Michael J. Finney, Ph.D. to Serve as Interim Chief Executive Officer SOUTH SAN FRANCISCO, Calif., Jan. 16, 2024 -- Vaxart, Inc. today...
Vaxart, Inc. (NASDAQ:VXRT) Q2 2023 Earnings Call Transcript August 3, 2023 Vaxart, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $0.19. Operator: Greetings, and welcome to the Vaxart Business Update and Second Quarter 2023 Financial Results Conference Call. A question-and-answer session will follow management’s opening remarks. Individual investors may submit written […]